Correlation of fasting and postprandial plasma glucose with HbA1c in assessing glycemic control; systematic review and meta-analysis

Archives of Public Health

Volumn 73, Issue 1, 2015, Pages

  Ketema, Ezra Belay ^a   Kibret, Kelemu Tilahun ^b  

^a MEKELLE UNIVERSITY   (Ethiopia)

^b WOLLEGA UNIVERSITY   (Ethiopia)

Author keywords

Correlation; Diabetes mellitus; Fasting plasma glucose; Glycemic control; HbA1c; Postprandial plasma glucose

Indexed keywords

EID: 84942155603     PISSN: 07787367     EISSN: 20493258     Source Type: Journal    
DOI: 10.1186/s13690-015-0088-6     Document Type: Review

References (41)

1. American Diabetes Association. Standards of medical care in diabetes. Diabetes Care. 2014;37:S14-80.
2. Sarah JB, Soma SN, Margaret J, Jeremy M, Shiva S, Charles M. Adequacy of glycemic, lipid, and blood pressure management for patients with diabetes in a managed care setting. Diabetes Care. 2004;27:694-8.
3. Vinod Mahato R, Gyawali P, Raut PP, Regmi P, Singh KP, Raj Pandeya DP, et al. Association between glycaemic control and serum lipid profile in type 2 diabetic patients: Glycated haemoglobin as a dual biomarker. Biomedical Researchm. 2011;22(3):375-80.
4. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352:837-53.
5. The Diabetes Control and Complications Trial Research Group. The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the Diabetes Control and Complications Trial. Diabetes. 1995;44:968-83.
6. Swetha NK. Comparison of fasting blood glucose & post prandial blood glucose with HbA1c in assessing the glycemic control. International J of Healthcare and Biomedical Research. 2014;2(3):134-9.
7. Ghazanfari Z, Haghdoost AA, Alizadeh SM, Atapour J, Zolala F. A comparison of HbA1c and fasting blood sugar tests in general population. Int J Prev Med. 2010;1(3):187-94.
8. Weykamp C, Garry John W, Mosca A. A review of the challenge in measuring hemoglobin A1c.journal of diabetes. Sci Technol. 2009;3(3):439-45.
9. Pasupathi P, Manivannan P M, Uma M, Deepa M. Glycated haemoglobin (HbA1c) as a stable indicator of type 2 diabetes Int J Pharm. Biomed Res. 2010;1(2):53-6.
10. Ken S. The correlation of hemoglobin A1c to blood glucose. J Diabetes Sci Technol. 2009;3(3):429-38.
11. Canadian Diabetes Association. Clinical practice guidelines: targets for glycemic control. Can J Diabetes. 2013;37:S31eS34.
12. Monnier L, Lapinski H, Colette C. Contributions of fasting and postprandial plasma glucose increments to the overall diurnal hyperglycemia of type 2 diabetic patients: variations with increasing levels of HbA (1c). Diabetes Care. 2003;26:481-85.
13. Rosediani M, Azidah AK, Mafauzy M. Correlation Between Fasting Plasma Glucose, Post Prandial Glucose and Glycated Haemoglobin and Fructosamine. Med JMalaysia. 2006;61(1):67-71.
14. Weerarathne TP, Dissanayake AS. Value of assessing post prandial blood glucose as a surrogate for fasting blood glucose in an outpatient medical clinic: a descriptive study. Galle Medical Journal. 2006;11(1):06-9.
15. Sheppard P, Bending JJ, Huber JW. Pre-and post-prandial capillary glucose self-monitoring achieves better glycaemic control than pre-prandial only monitoring: A study in insulin treated diabetic patients. Practical Diabetes Int. 2005;22(1):15-22.
16. Leeflang MM, Deeks JJ, Gatsonis C, Bossuyt PM. Cochrane Diagnostic Test Accuracy Working Group. Systematic reviews of diagnostic test accuracy Ann Intern Med. 2008;149:889-97.
17. Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med, 2009;6(7):e1000097.
18. Kohnert KD et al. Utility of different glycemic control metrics for optimizing management of diabetes. World J Diabetes. 2015;6(1):17-29.
19. Borenstein M, Hedges LV, Higgins JPT, Rothstein HR. Introduction to meta-analysis. 1st ed. West Sussex, United Kingdom: John Wiley & Sons Ltd. Chichester; 2009.
20. Saed MK. Postprandial blood glucose as a marker of glycemic control in type 2 sudanese diabetics sudanese. jpublic health. 2006;4(1):278-88.
21. Haddadinezhad S, Ghazaleh N. Relation of fasting and postprandial and plasm glucose to hemoglobin A1c in diabetics. Int J Diab dev ctries. 2010;30(1):8-10.
22. Gupta S, Puppalwar PV, Chalak A. Correlation of fasting and post meal plasma glucose level to increased HbA1c levels in type-2 diabetes mellitus. Int J Adv Med. 2014;1:127-31.
23. Datta S, Pal M, Mitra R, Ganguly A, Basu S, Manna s. Value of assessing post prandial and fasting plasma glucose as a surrogate for glycated hemoglobin in diabetic glycemic control. World Journal of Pharmaceutical Research. 2014;3(9):494-503.
24. Avignon A, Radauceanu A, Monnier L. Nonfasting plasma glucose is a better marker of diabetic control than fasting plasma glucose in type 2 diabetes. Diabetes Care. 1997;20:1822.1826.
25. Bonora E, Francesco C, Simonetta L, Bonfante N. Plasma glucose levels throughout the day and HbA1c interrelationships in type 2 diabetes: Implications for treatment and monitoring of metabolic control. Diabetes Care. 2001;24:2023-9.
26. Shrestha L et al. Correlation between fasting blood glucose, postprandial blood glucose and glycated hemoglobin in non insulin treated type 2 diabetic subjects. Sunsari Technical College Journal. 2012;1(1):18-21.
27. Azim W, Mushtaq Gill M, Azim S, Farooq W. Assessment of fasting and twohour post-prandial glucose as an economical test for monitoring of glycemic control, compared to glycated haemoglobin. Med Channel., 2011;17(2):5-7.
28. Saiedullah M, Hayat S, Kamaluddin SM, Begum S. Correlation of Fasting and Post Prandial Plasma Glucose with Hemoglobin Glycation. AKMMC J. 2013;4(2):28-30.
29. Woerle HJ, Neumann C, Zschau S, Tenner S, Irsigler A, Schirra J, et al. Impact of fasting and postprandial glycemia on overall glycemic control in type 2 diabetes Importance of postprandial glycemia to achieve target HbA1c levels. Diabetes Res Clin Pract. 2007;77:280-5.
30. Schernthaner G, Guerci B, Gallwitz L, Rosediani M, Nicolay C, Kraus P, et al. Impact of postprandial and fasting glucose concentration on HbA1c in pateints with type 2 diabetes. Diabetes Metab. 2010;36:389-94.
31. Ceriello A, Colagiuri S, Gerich J, Tuomilehto J. Guideline for management of postmeal glucose. Nutr Metab Cardiovasc Dis. 2008;18(4):S17-33.
32. Sharon H, Judith F, Catherine C. Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes. J Am Med Assoc. 2004;291:335-42.
33. Kilpatrick ES. Haemoglobin A1c in the diagnosis and monitoring of diabetes mellitus. J Clin Pathol. 2008;61(9):977-82.
34. Bloomgarden ZT. A1c: recommendations, debates, and questions. Diabetes Care. 2009;32(12):141-7.
35. Kohnert KD, Augstein P, Heinke P, Zander E, Peterson K, Freyse EJ, et al. Chronic hyperglycemia but not glucose variability determines HbA1c levels in well-controlled patients with type 2 diabetes. Diabetes Res Clin Pract. 2007;77:420-6.
36. Haffner S. The importance of postprandial hyperglycaemia in development of cardiovascular disease in people with diabetes. Int J Clin Pract. 2001;123(suppl):24-6.
37. International Diabetes Federation, 2011 Guideline for Management of PostMeal Glucose in Diabetes. 2011;1-37.
38. Hanefeld M, Cagatay M, Petrowitsch T, Neuser D, Petzinna D, Rupp M. Acarbose reduces the risk for myocardial infarction in type 2 diabetic patients: meta-analysis of seven long-term studies. Eur Heart J. 2004;25(1):10-6.
39. Kovatchev B, Cox DJ, Summers KH, Gonder-Frederick L, Clarke WL. Postprandial glucose dynamics and associated symptoms in type 2 diabetes mellitus. The Journal of Applied Research. 2003;3(4):449-58.
40. Szoke E, Shrayyef MZ, Messing S. Effect of aging on glucose homeostasis: accelerated deterioration of beta-cell function in individuals with impaired glucose tolerance. Diabetes Care. 2008;31:539-43.
41. Monnier L, Colette C. Target for glycemic control:concentrating on glucose. Diabetes Care. 2009;32(2):s199-204.